PCN84 COST-EFFECTIVENESS ANALYSES OF DOCETAXEL VERSUS PACLITAXEL ONCE WEEKLY IN PATIENTS WITH METASTATIC BREAST CANCER PROGRESSED AFTER ANTHRACYCLINE CHEMOTHERAPY IN SPAIN

Autor: Cortés, J, Seguí, MA, Frias, C, Betegón, L, Oyagüez, I, Casado, MA
Zdroj: In Value in Health 2009 12(7):A272-A272
Databáze: ScienceDirect